Rheumatology Advance Access published online on March 9, 2006
Rheumatology, doi:10.1093/rheumatology/kel061
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute for Cell Biology, Department of Immunology, University of Tübingen, Germany
* To whom correspondence should be addressed. Objectives. Dendritic cells (DCs) play a key role in regulating immune responses, especially in priming naïve T-cells. Recently, DCs have been suggested to be involved in systemic lupus erythematosus (SLE) development by activating autoreactive T-helper lymphocytes. As a consequence, we compared the activation state of human monocyte-derived DCs (MDDCs) obtained from lupus patients and normal individuals. Methods. The MDDCs were generated in vitro from blood from healthy donors and lupus patients. Immature and mature MDDCs were analysed by flow cytometry for several cell surface molecules. In parallel, cytokine secretion was determined by ELISA before and after MDDC activation. In each experiment, lupus DCs were compared with normal DCs. Results. Here, we show for the first time that lupus MDDCs spontaneously over-express CD86 in the absence of any DC activation signal as compared with normal MDDCs (P=0.025). Moreover, activation-induced IL-6 secretion was increased in lupus DCs with high CD86 over-expression as compared with normal DCs (P=0.010). Interestingly, the percentage of MDDCs in lupus preparations is negatively correlated with disease activity scores (SLEDAI; P=0.031). Conclusions. Lupus MDDCs are pre-activated suggesting that they might be more efficient antigen-presenting cells. This result might partly explain how the peripheral tolerance is broken in SLE.
Received July 28, 2005
Accepted January 31, 2006
Original Papers
Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus
Patrice Decker 1 *,
Ina Kötter 2,
Reinhild Klein 2,
Beate Berner 2,
and
Hans-Georg Rammensee 1
2 Internal Medicine II, University Hospital, Tübingen, Germany
Patrice Decker, E-mail: patrice.decker{at}uni-tuebingen.de
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A.-M. Fairhurst, C. Xie, Y. Fu, A. Wang, C. Boudreaux, X. J. Zhou, R. Cibotti, A. Coyle, J. E. Connolly, E. K. Wakeland, et al. Type I Interferons Produced by Resident Renal Cells May Promote End-Organ Disease in Autoantibody-Mediated Glomerulonephritis J. Immunol., November 15, 2009; 183(10): 6831 - 6838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Crispin, M. Oukka, G. Bayliss, R. A. Cohen, C. A. Van Beek, I. E. Stillman, V. C. Kyttaris, Y.-T. Juang, and G. C. Tsokos Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys J. Immunol., December 15, 2008; 181(12): 8761 - 8766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mozaffarian, A. E. Wiedeman, and A. M. Stevens Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1 Rheumatology, September 1, 2008; 47(9): 1335 - 1341. [Abstract] [Full Text] [PDF]
|
|